ABBOTT LABORATORIES — Director's Dealing 2015

Jun 3, 2015

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2015-06-01

Reporting Person: YOOR BRIAN B (Senior Vice President and CFO)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	18146	Direct
Common shares without par value	2043	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Option (right to buy)	$34.94	2023-02-14	Common shares (11400)		Direct
Option (right to buy)	$39.12	2024-02-20	Common shares (10788)		Direct
Option (right to buy)	$39.12	2024-02-20	Common shares (10787)		Direct
Option (right to buy)	$39.12	2024-02-20	Common shares (10788)		Direct
Option (right to buy)	$47.00	2025-02-19	Common shares (13743)		Direct
Option (right to buy)	$47.00	2025-02-19	Common shares (13743)		Direct
Option (right to buy)	$47.00	2025-02-19	Common shares (13743)		Direct

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of June 1, 2015.

F2: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.